MP
IQMDU

Mangrove Partners’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Mangrove Partners’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-173,770
Closed -$1.76M – 624
2022
Q1 		$1.76M Sell
173,770
-26,230
-13% -$265K 0.09% 326
2021
Q4 		$2.04M Buy
+200,000
New +$2.03M 0.12% 239

Other funds holding IQMDU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Mangrove Partners's IQMDU Position: Q2 2022 in Review

Mangrove Partners sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q2 2022, closing a stake of 173,770 shares — an estimated $1.76M sold.

Mangrove Partners first reported a position in IQMDU in Q4 2021 and held it in 2 quarters. The position peaked at $2.04M in Q4 2021. 26 funds tracked by Wall St. Rank hold IQMDU as of Q2 2022.

  • Mangrove Partners reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q2 2022 after selling out during the quarter.
  • Mangrove Partners sold 173,770 Intelligent Medicine Acquisition Corp. Unit shares in Q2 2022, an estimated $1.76M.
  • Mangrove Partners first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 2 quarters.
  • Mangrove Partners's Intelligent Medicine Acquisition Corp. Unit position peaked at $2.04M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q2 2022.

Based on Mangrove Partners's 13F filing for Q2 2022, filed 15 Aug 2022.